Terms: = Thyroid cancer AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K AND Clinical Outcome
3 results:
1. A clinical trial of somatic and germline analyses for healthy longevity in a postoperative cancer patient.
Hayashi N; Kuroda Y; Saito T; Tsuruda Y; Niida A; Otsu H; Eguchi H; Masuda T; Suzuki Y; Natsugoe S; Mimori K
Surg Today; 2019 Sep; 49(9):738-747. PubMed ID: 30843125
[TBL] [Abstract] [Full Text] [Related]
2. Genetic profiling of advanced radioactive iodine-resistant differentiated thyroid cancer and correlation with axitinib efficacy.
Schechter RB; Nagilla M; Joseph L; Reddy P; Khattri A; Watson S; Locati LD; Licitra L; Greco A; Pelosi G; Carcangiu ML; Lingen MW; Seiwert TY; Cohen EE
Cancer Lett; 2015 Apr; 359(2):269-74. PubMed ID: 25641339
[TBL] [Abstract] [Full Text] [Related]
3. Molecular biology of thyroid cancer initiation.
Riesco-Eizaguirre G; Santisteban P
Clin Transl Oncol; 2007 Nov; 9(11):686-93. PubMed ID: 18055323
[TBL] [Abstract] [Full Text] [Related]
